USA flag logo/image

An Official Website of the United States Government

High Resolution and High Contrast Near-IR Imaging of the Human Fundus

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
80899
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
EY016264
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Iris AO, Inc.
2680 Bancroft Way Berkeley, CA 94704-1717
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2006
Title: High Resolution and High Contrast Near-IR Imaging of the Human Fundus
Agency: HHS
Contract: 1R43EY016264-01A2
Award Amount: $99,865.00
 

Abstract:

DESCRIPTION (provided by applicant): This Phase I SBIR will prove the feasibility of a design for a confocal scanning laser ophthalmoscope (cSLO) that can take high-resolution in-vivo images of the human eye. This cSLO will use long wavelength sources to permit deeper imaging than conventional cSLOs. More importantly, the system will incorporate micro-electro-mechanical adaptive optics (MEMS-AO) to dynamically correct the optical aberrations that currently preclude high-resolution imaging of these deeper layers. By combining these two technologies, it will be possible for the first time to observe, in vivo, currently irresolvable features of the human eye. Because many degenerative retinal diseases originate in these deep layers, such a system promises to boost our understanding of and ability to treat a host of debilitating eye diseases. After construction of a working prototype during Phase II, Iris AO will refine and test it by focusing primarily on age-related macular degenernd deformable mirror control, (2) MEMS mirror coating and packaging, (3) wide field imaging and fixation development, (4) experimental long wavelength imaging, (5) detailed ZEMAX optical system design. Phase II prototyping and Phase III commercialization will result in a general purpose, deep-imaging cSLO. Eye disease blinds thousands of Americans and degrades the eye sight of millions more. Under this proposal, new imaging technology will be developed to fight debilitating eye disease resulting in earlier disease detection, faster drug clinical trials, and better medical understanding.

Principal Investigator:

Nathan P. Doble
5108492375
NATHAN.DOBLE@IRISAO.COM

Business Contact:

Michael Helmbrecht
5108492375
MICHAEL.HELMBRECHT@IRISAO.COM
Small Business Information at Submission:

IRIS AO, INC.
IRIS AO, INC. 2680 BANCROFT WAY BERKELEY, CA 94704

EIN/Tax ID: 043693091
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No